When developing drugs, we rely heavily on in vitro, in vivo animal and in silico models to predict how the human body will interact with drugs before
How in vitro human Gut/Liver models increase confidence in ADME estimations before human trials
Imagine a world where developing new medicines is faster, cheaper, and less reliant on the use of animals for testing. Novel multi-organ in vitro
Organ-on-a-chip adoption: The roadmap to broader use
Paving the way for Organ-on-a-chip adoption Drug discovery is becoming more complex as we move from a small molecule world to large molecules and
Global Fatty Liver Day 2024: How Organ-on-a-Chip Addresses R&D Challenges
To commemorate Global Fatty Liver Day on June 13, this article explores how organ-on-a-chip models are transforming liver disease research. Over
Meet the CN Bio team -Dr. Dharaminder Singh
Welcome to our new "Meet the team" blog series, where you'll get a behind-the-scenes look at the incredible individuals who make our company
Understanding the mechanism of toxicity: OOC’s crucial role
It’s commonly acknowledged that the current drug discovery process is inefficient with large numbers of drugs failing in the clinic. Almost a third
A guide to pre-validating primary cells for use in Organ-on-a-chip assays
Mirror, mirror on the wall, which is the best cell of them all? If you are considering incorporating Organ-on-a-chip (OOC) technology into your
Immune-mediated DILI – Predicting the unpredictable!
Different types of Drug-induced Liver Injury (DILI) Drug-induced liver injury (DILI) is a longstanding and significant problem for clinicians,
The U.S. FDA Modernization Act 2.0. Now the animal testing mandate is removed, learn what can be embraced in its place.
What is the FDA Modernization Act 2.0, and what does it mean? The U.S. Food and Drug Administration (FDA) are the federal agency tasked with